Addressing hepatitis C-related discrimination in a post-cure world. This project aims to address the legal and policy dimensions of hepatitis C discrimination. Hepatitis C is a major public health challenge linked to profound discrimination, including in law and policy. Treatments introduced in 2016 improved cure rates; optimism about disease elimination is high, but questions remain about discrimination faced by those who are cured. This interdisciplinary project’s goal is to generate new knowl ....Addressing hepatitis C-related discrimination in a post-cure world. This project aims to address the legal and policy dimensions of hepatitis C discrimination. Hepatitis C is a major public health challenge linked to profound discrimination, including in law and policy. Treatments introduced in 2016 improved cure rates; optimism about disease elimination is high, but questions remain about discrimination faced by those who are cured. This interdisciplinary project’s goal is to generate new knowledge about hepatitis C discrimination in a post-cure context, and identify opportunities for legal and policy reform. Expected outcomes of the project include better legal, social and policy outcomes for Australians cured of hepatitis C, significantly benefiting these individuals directly and society more broadly.Read moreRead less
Lived experiences of treatment for hepatitis C in Australia. This project aims to support uptake of new hepatitis C treatments. With the introduction of new treatments in 2016, the Australian Government adopted the WHO’s goal of eliminating the disease by 2030. While early treatment rates were high, they have since plateaued, with stigma and poor information considered key obstacles. This project will generate new knowledge on treatment decisions and experiences, using a proven qualitative metho ....Lived experiences of treatment for hepatitis C in Australia. This project aims to support uptake of new hepatitis C treatments. With the introduction of new treatments in 2016, the Australian Government adopted the WHO’s goal of eliminating the disease by 2030. While early treatment rates were high, they have since plateaued, with stigma and poor information considered key obstacles. This project will generate new knowledge on treatment decisions and experiences, using a proven qualitative methodology. In doing so, it will produce a website covering personal experiences of treatment, issues in treatment decision-making, and advice on enhancing life on treatment and after. It will tackle hepatitis C-related stigma, and inform and benefit potential treatment users, families and relevant professionals.
Read moreRead less
Using genetic Allee effects to manage invasive populations. An invasion can be started with only a small number of individuals, and it is very difficult to reliably detect these individuals. This project aims to develop new genetic technology that can send small founder populations extinct without affecting large populations. This technology removes the problem of having to detect small populations; these small populations will go extinct on their own, without the need for management interventio ....Using genetic Allee effects to manage invasive populations. An invasion can be started with only a small number of individuals, and it is very difficult to reliably detect these individuals. This project aims to develop new genetic technology that can send small founder populations extinct without affecting large populations. This technology removes the problem of having to detect small populations; these small populations will go extinct on their own, without the need for management intervention. This technology could be used to prevent establishment and spread of invasive species and agricultural pests. Through a combination of experimentation and modelling, the project develops this technology and assesses its use in applied problems ranging across environment, agriculture, and health.Read moreRead less
Investigating the molecular basis of T-cell receptor cross-reactivity. This project will explore the basis of unexpected immune reactions whereby the immune system mistakes one molecular structure for another, a phenomenon known as cross-reactivity. This project will examine how often this is due to molecular mimicry, potentially explaining why immune T cells sometimes react inappropriately to different agents.